<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="spec_case_control_types_rel3" dataset_id="pht003417.v3" study_name="Women's Health Initiative" study_id="phs000200.v11" participant_set="3" date_created="06/14/2017"><description>Specimen Study Case-Control Types</description><variable id="phv00193840.v3.p3" var_name="SUBJID" calculated_type="string" reported_type="integer"><description>WHI dbGaP Subject ID</description><total><subject_profile><sex><female>68904</female></sex></subject_profile><stats><stat n="68904" nulls="0"/></stats></total></variable><variable id="phv00193840.v3.p3.c1" var_name="SUBJID" calculated_type="string" reported_type="integer"><description>WHI dbGaP Subject ID</description><total><subject_profile><sex><female>59002</female></sex></subject_profile><stats><stat n="59002" nulls="0"/></stats></total></variable><variable id="phv00193840.v3.p3.c2" var_name="SUBJID" calculated_type="string" reported_type="integer"><description>WHI dbGaP Subject ID</description><total><subject_profile><sex><female>9902</female></sex></subject_profile><stats><stat n="9902" nulls="0"/></stats></total></variable><variable id="phv00193841.v3.p3" var_name="STUDYID" calculated_type="enum_integer" reported_type="encoded value"><description>Study ID</description><total><subject_profile><sex><female>68904</female></sex></subject_profile><stats><stat n="68904" nulls="0" mean_count="2223" sd="2794" median_count="1385" min_count="53" max_count="11966"/><example code="W54" count="11966">CVD Biomarkers for 2010-2015 (SHARe cohort only)</example><example code="W58" count="10160">CVD, diabetes, and renal biomarkers in the EA HT Cohort</example><example code="W64" count="7451">Long Life Study (LLS)</example><example code="W1" count="4122">CT 6% Subsample, Clinic CBCs, QC Pools</example><example code="W15" count="3411">Vit D and colorectal cancer or fractures in CaD trial</example><example code="BA25" count="3361">Leukocyte Telomere Dynamics</example><example code="132" count="3136">Genetic and biochemical predictors of type 2 diabetes</example><example code="BA10" count="2197">Adipokines and risk of obesity-related disease</example><example code="W24" count="2045">Vitamin D and breast cancer in CaD trial</example><example code="BA9" count="1854">Biochemical antecedents of fracture in minority women</example></stats></total></variable><variable id="phv00193841.v3.p3.c1" var_name="STUDYID" calculated_type="enum_integer" reported_type="encoded value"><description>Study ID</description><total><subject_profile><sex><female>59002</female></sex></subject_profile><stats><stat n="59002" nulls="0" mean_count="1903" sd="2539" median_count="1183" min_count="51" max_count="10808"/><example code="W54" count="10808">CVD Biomarkers for 2010-2015 (SHARe cohort only)</example><example code="W58" count="8610">CVD, diabetes, and renal biomarkers in the EA HT Cohort</example><example code="W64" count="7420">Long Life Study (LLS)</example><example code="W1" count="3486">CT 6% Subsample, Clinic CBCs, QC Pools</example><example code="BA25" count="3086">Leukocyte Telomere Dynamics</example><example code="W15" count="3010">Vit D and colorectal cancer or fractures in CaD trial</example><example code="132" count="2420">Genetic and biochemical predictors of type 2 diabetes</example><example code="W24" count="1877">Vitamin D and breast cancer in CaD trial</example><example code="BA10" count="1662">Adipokines and risk of obesity-related disease</example><example code="W66" count="1420">Long Life Study-Phase III Biomarkers and GWAS</example></stats></total></variable><variable id="phv00193841.v3.p3.c2" var_name="STUDYID" calculated_type="enum_integer" reported_type="encoded value"><description>Study ID</description><total><subject_profile><sex><female>9902</female></sex></subject_profile><stats><stat n="9902" nulls="0" mean_count="319.4" sd="341.1" median_count="201" min_count="2" max_count="1550"/><example code="W58" count="1550">CVD, diabetes, and renal biomarkers in the EA HT Cohort</example><example code="W54" count="1158">CVD Biomarkers for 2010-2015 (SHARe cohort only)</example><example code="132" count="716">Genetic and biochemical predictors of type 2 diabetes</example><example code="W1" count="636">CT 6% Subsample, Clinic CBCs, QC Pools</example><example code="126" count="541">Stroke risk factors and molecular markers</example><example code="BA10" count="535">Adipokines and risk of obesity-related disease</example><example code="BA9" count="497">Biochemical antecedents of fracture in minority women</example><example code="W6" count="478">HT CVD Biomarkers: study of CHD, Stroke and VTE - Phase I</example><example code="W14" count="478">CVD biomarkers - Phase I: additional asays</example><example code="W15" count="401">Vit D and colorectal cancer or fractures in CaD trial</example></stats></total></variable><variable id="phv00193842.v3.p3" var_name="CCNAME" calculated_type="string" reported_type="string"><description>Case Control Type Name</description><comment>A short name describing the case control type.</comment><total><subject_profile><sex><female>68904</female></sex></subject_profile><stats><stat n="68904" nulls="0" mean_count="1188" sd="2489" median_count="206" min_count="2" max_count="11966" distinct_vals="58"/><example count="11966">Ppts from SHARe (M5)</example><example count="9442">Case</example><example count="8091">Control</example><example count="7451">Participants</example><example count="4949">Study ppt</example><example count="4632">WHIMS ppts</example><example count="4305">GARNET ppts</example><example count="2476">Matched Control</example><example count="1491">W64 eligible ppts not in W54 or W58</example><example count="1329">Cohort B</example></stats></total></variable><variable id="phv00193842.v3.p3.c1" var_name="CCNAME" calculated_type="string" reported_type="string"><description>Case Control Type Name</description><comment>A short name describing the case control type.</comment><total><subject_profile><sex><female>59002</female></sex></subject_profile><stats><stat n="59002" nulls="0" mean_count="1017" sd="2188" median_count="169.5" min_count="2" max_count="10808" distinct_vals="58"/><example count="10808">Ppts from SHARe (M5)</example><example count="7420">Participants</example><example count="7330">Case</example><example count="6998">Control</example><example count="4178">WHIMS ppts</example><example count="4077">Study ppt</example><example count="3355">GARNET ppts</example><example count="2040">Matched Control</example><example count="1420">W64 eligible ppts not in W54 or W58</example><example count="1327">Cohort B</example></stats></total></variable><variable id="phv00193842.v3.p3.c2" var_name="CCNAME" calculated_type="string" reported_type="string"><description>Case Control Type Name</description><comment>A short name describing the case control type.</comment><total><subject_profile><sex><female>9902</female></sex></subject_profile><stats><stat n="9902" nulls="0" mean_count="186.8" sd="381.2" median_count="42" min_count="2" max_count="2112" distinct_vals="53"/><example count="2112">Case</example><example count="1158">Ppts from SHARe (M5)</example><example count="1093">Control</example><example count="950">GARNET ppts</example><example count="872">Study ppt</example><example count="454">WHIMS ppts</example><example count="436">Matched Control</example><example count="231">Cohort A - Death</example><example count="201">Study ppts</example><example count="190">CHD event after Y2 Case</example></stats></total></variable><variable id="phv00193843.v3.p3" var_name="CASEFLG" calculated_type="enum_integer" reported_type="encoded value"><description>Case Flag</description><comment>Y=Case, N=Control, N/A=Study was not a case/control design.
		Note that in some studies the same participant may act as both a case and a control (e.g. studies looking at multiple outcomes). </comment><total><subject_profile><sex><female>68904</female></sex></subject_profile><stats><stat n="68904" nulls="0" mean_count="22968" sd="13346" median_count="17193" min_count="13482" max_count="38229"/><enum code="NA" count="38229">Not Applicable</enum><enum code="Y" count="17193">Yes - Case</enum><enum code="N" count="13482">No - Control</enum></stats></total></variable><variable id="phv00193843.v3.p3.c1" var_name="CASEFLG" calculated_type="enum_integer" reported_type="encoded value"><description>Case Flag</description><comment>Y=Case, N=Control, N/A=Study was not a case/control design.
		Note that in some studies the same participant may act as both a case and a control (e.g. studies looking at multiple outcomes). </comment><total><subject_profile><sex><female>59002</female></sex></subject_profile><stats><stat n="59002" nulls="0" mean_count="19667" sd="12652" median_count="13176" min_count="11579" max_count="34247"/><enum code="NA" count="34247">Not Applicable</enum><enum code="Y" count="13176">Yes - Case</enum><enum code="N" count="11579">No - Control</enum></stats></total></variable><variable id="phv00193843.v3.p3.c2" var_name="CASEFLG" calculated_type="enum_integer" reported_type="encoded value"><description>Case Flag</description><comment>Y=Case, N=Control, N/A=Study was not a case/control design.
		Note that in some studies the same participant may act as both a case and a control (e.g. studies looking at multiple outcomes). </comment><total><subject_profile><sex><female>9902</female></sex></subject_profile><stats><stat n="9902" nulls="0" mean_count="3301" sd="1211" median_count="3982" min_count="1903" max_count="4017"/><enum code="Y" count="4017">Yes - Case</enum><enum code="NA" count="3982">Not Applicable</enum><enum code="N" count="1903">No - Control</enum></stats></total></variable></data_table>
